All material on this website is aimed at healthcare professionals working in BaNES, Swindon and Wiltshire.

Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or out of hours contact the NHS 111 service by telephoning 111.

Here you can find our local commissioning policies for drugs that do not have NICE technology appraisals for the specific indication

All
  • All
  • Clinical
  • Policy

Infliximab Dose Escalation Policy for IBD

crohn’s diseasecrohnsulcerative colitisinflammatory bowel disease  39 total views,  1 views today

 39 total views,  1 views today

Vedolizumab Dose Escalation Policy for IBD

crohn’s diseasecrohnsulcerative colitisInflammatory bowel disease  39 total views,  1 views today

 39 total views,  1 views today

Policy for Funding Flash Glucose Monitoring for People with Diabetes

freestyle librelibre 2diabetestype 1 diabetestype 1type 2 diabetestype 2  39 total views,  1 views today

 39 total views,  1 views today

Sativex commissioning statement March 2021

Cannabis MS spasticity sativex  40 total views,  1 views today

 40 total views,  1 views today

Use of Qutenza Patches in Adults for Peripheral Neuropathic pain in non-diabetic patients: Prior Approval Form

Capsaicin qutenza neuropathic pain pain  39 total views,  1 views today

 39 total views,  1 views today

Ustekinumab Dose Escalation Policy for Crohn’s Disease

crohnsInflammatory bowel disease  39 total views,  1 views today

 39 total views,  1 views today

Qutenza patch (capsaicin 8%) for peripheral neuropathic pain in non-diabetic patients commissioning statement: Low priority intervention

Capsaicin qutenza neuropathic pain pain  39 total views,  1 views today

 39 total views,  1 views today

Bevacizumab for the treatment of rubeotic/neovascular glaucoma and uncontrolled Proliferative Diabetic Retinopathy prior to laser or vitrectomy (adults)

Rubeotic glaucoma neovascular glaucoma Proliferative Diabetic Retinopathy bevacizumab  39 total views,  1 views today

 39 total views,  1 views today

Policy for use of Avastin® (bevacizumab) under the NICE threshold in wet AMD

Bevacizumab avastin wet AMD Ranibizumab Aflibercept  39 total views,  1 views today

 39 total views,  1 views today

Policy for dose escalation of Ustekinumab in psoriasis or psoriatic arthritis

Ustekinumab psoriasis psoriatic arthritis  39 total views,  1 views today

 39 total views,  1 views today